Skip to main content
Clinical Trials/EUCTR2021-000941-42-ES
EUCTR2021-000941-42-ES
Active, not recruiting
Phase 1

The impact of the intensity of ovarian stimulation on embryo quality in predicted suboptimal responders. A randomized controlled trial. - INTENS-EQ_trial

Fundacion Santiago Dexeus Font0 sites100 target enrollmentJune 11, 2021

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
To compare the number of GQB and the morphokinetic parameters of early embryo development in infertile suboptimal patients undergoing two different intensities of ovarian stimulation, a milder approach ( Clomiphene Citrate (CC) 50mg/day plus 150IU daily dose of rFSH) and a more intense approach (300IU daily dose of rFSH).
Sponsor
Fundacion Santiago Dexeus Font
Enrollment
100
Status
Active, not recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 11, 2021
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
Female

Investigators

Sponsor
Fundacion Santiago Dexeus Font

Eligibility Criteria

Inclusion Criteria

  • AFC \= 5 and \= 10
  • AMH \=1\.5 ng/ml (AMH result of up to one year will be valid)
  • Age \= 35 years and \=40 years
  • BMI \>\=18\.5 and \<25 kg/m2
  • Willing to participate in the study
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 100
  • F.1\.3 Elderly (\>\=65 years) no

Exclusion Criteria

  • History of untreated autoimmune, endocrine or metabolic disorders
  • Contraindication for hormonal treatment
  • Preimplantation genetic diagnosis
  • Severe male factor (sperm concentration \<5M/mL)
  • Recent history of severe disease requiring regular treatment (clinically significant concurrent medical condition that could compromise subject safety or interfered with the trial assessment and patients with any contraindication of being pregnant).

Outcomes

Primary Outcomes

Not specified

Similar Trials